502- Psychedelic Therapy for Mood Disorders: Research & Potential
May 14, 2024
auto_awesome
Dr. Ambrose discusses the research on psychedelic therapy for mood disorders using substances like psilocybin, ketamine, MDMA, and LSD. They explore the therapeutic potential, historical perspectives, biochemical mechanisms, and complexities of psychedelic therapy while advocating for a responsible and inclusive approach to integration into psychiatric treatment.
Psychedelic therapy shows promise in treating mood disorders like major depressive disorder through compounds like psilocybin and MDMA.
Psychedelic-assisted psychotherapy emphasizes the importance of set and setting for optimal therapeutic outcomes and patient experiences.
Deep dives
Understanding Psychedelic Therapy Potential
The podcast explores the historical context and promising potential of psychedelic therapy for mood disorders such as major depressive disorder. Psychedelics like psilocybin, ketamine, MDMA, and LSD are discussed for their therapeutic benefits and side effects, emphasizing the need for open and honest conversations about their current state.
Psychopharmacology and Effects of Psychedelics
It delves into the pharmacology and effects of psychedelics on sensory perception, emotional experiences, and physiological responses. Different psychedelic compounds like LSD, DMT, and MDMA are outlined, illustrating their diverse interactions and visual, cognitive, and emotional impacts on users.
Psychedelic-Assisted Psychotherapy Process
The podcast details the components and stages of psychedelic-assisted psychotherapy, emphasizing the importance of set and setting for mindset and environmental context. It explains the preparatory, dosing, and integrative sessions, highlighting the therapeutic goals, patient experiences, and outcomes.
Balancing Promises and Risks of Psychedelic Usage
A discussion on balancing the promises and concerns of psychedelic therapy, addressing clinical utility, safety, ethical considerations, and cultural sensitivity. The podcast advocates for informed decision-making, provider trust, and understanding potential risks of addiction, dependence, abuse, and adverse psychological effects.
Learn about new and ongoing research about the safety and efficacy of psychedelic drugs like psilocybin, ketamine, MDMA, and LSD to treat mood disorders and other conditions from Adrian Jacques H. Ambrose, M.D.
Thank you for listening to ADDitude's ADHD Experts podcast. Please consider subscribing to the magazine (additu.de/subscribe) to support our mission of providing ADHD education and support.
Get the Snipd podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered podcast player
Listen to all your favourite podcasts with AI-powered features
Discover highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share & Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered podcast player
Listen to all your favourite podcasts with AI-powered features
Discover highlights
Listen to the best highlights from the podcasts you love and dive into the full episode